Brief: Pmv Pharmaceuticals Announces Initial Pc14586 Phase 1 Clinical Data To Be Presented At The 2022 American Society Of Clinical Oncology (Asco) Annual Meeting
27/05/2022 24:52
May 26 (Reuters) - PMV Pharmaceuticals Inc PMVP.O :
* PMV PHARMACEUTICALS ANNOUNCES INITIAL PC14586 PHASE 1
CLINICAL
DATA TO BE PRESENTED AT THE 2022 AMERICAN SOCIETY OF CLINICAL
ONCOLOGY (ASCO) ANNUAL MEETING
Source text for Eikon: ID:nGNX7vTvxM
Further company coverage: PMVP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics